The potential applications of gene editing technologies for treating diseases are beginning to be realised. The science underpinning gene editing medicines continues to develop at a rapid pace, and clinical applications are growing. However, challenges in terms of manufacturing, scale-up, regulation, equitable access, health economics and safety make the widespread roll-out of these medicines difficult.
This two-day conference will discuss recent advances, future priorities, and the wider social and economic context for the application of gene editing approaches in a healthcare setting.
This registration is for virtual attendance. In person is by invitation only and at the discretion of the organisers. Please email industry@royalsociety.org to inquire.
